Evonik stock: BASF ends takeover pursuit after two bids rejected
Published on 11/19/2026 at 17:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat BASF's decision changes
- BASF said Evonik rejected two non-binding all-cash offers and that a higher valuation was not justified.
- Evonik's standalone prospects and the risks of a transaction were central to BASF's decision.
- The takeover debate now shifts from a possible renewed offer to Evonik's independent strategy.
BASF ended its effort to acquire Evonik on Thursday, November 19, 2026, after Evonik rejected two non-binding all-cash offers. In its statement, BASF said Evonik's Executive Board had not shown meaningful engagement and that its assessment of Evonik's standalone prospects and related risks did not justify pursuing a higher valuation.
Why BASF withdrew
BASF said its latest offer of 24 euros per share would have created significant additional value for Evonik shareholders. The group nevertheless concluded that pursuing the transaction at a higher price would not serve BASF shareholders' interests.
The decision follows days of resistance to a potential combination. Evonik management has supported an independent path, while political opposition in North Rhine-Westphalia has complicated efforts to win backing for a transaction.
Share price and investor context
Evonik stock traded at 18.35 euros on Lang & Schwarz at 17:04 CET on Thursday, November 19, 2026, 15.52 percent below the Xetra close of Wednesday, November 18. Since the own report of November 18, when the share traded at 21.73 euros at 17:45 CET, the price was down 15.55 percent.
For investors, the end of BASF's pursuit removes the immediate prospect of a takeover premium. Attention can now return to Evonik's standalone strategy, operating performance and the next company disclosures.
Evonik Industries AG at a glance
- ISIN: DE000EVNK013
- Lang & Schwarz price: 18.35 euros at 17:04 CET on November 19, 2026
- Xetra close: 21.78 euros on November 18, 2026
- Home market: Germany
German equities remain in focus in current market reports.
